Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103116
Status:
COMPLETED
Last Update Posted:
2017-04-04
First Post:
2005-02-07
Brief Title:
Vaccine Therapy in Treating Patients With Stage I Stage II or Stage III Non-small Cell Lung Cancer
Sponsor:
Edward Hirschowitz
Organization:
University of Kentucky
Organization Data
Organization:
University of Kentucky
Class:
OTHER
Study ID:
CDR0000410830
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Edward Hirschowitz
Lead Sponsor Class:
OTHER
Responsible Party:
Edward Hirschowitz
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Kentucky
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |